Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neuroscience. To learn is to myelinate.
Restless legs syndrome heralding an acute exacerbation of multiple sclerosis.
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy.
159 Microsurgical descending tractotomy in cases of intractable trigeminal pain syndromes.
The precise chemical-physical nature of the pharmacore in FK506 binding protein inhibition: ElteX, a new class of nanomolar FKBP12 ligands.
Combined sequence-based and genetic mapping analysis of complex traits in outbred rats.
Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors.
The radiologically isolated syndrome.
Optical Coherence Tomography Detection of Neurodegeneration in Multiple Sclerosis.
Immune Therapy of Multiple Sclerosis - Future Strategies.
How safe could intrathecal transplantation of mesenchymal stem cells be considered in multiple sclerosis?-Reply.
Cognitive reserve and patient-reported outcomes in multiple sclerosis.
Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy.
The cuprizone model: regional heterogeneity of pathology.
Could behavioral therapies target specific deficits in multiple sclerosis patients?
Post-infective transverse myelitis following Streptococcus pneumoniae meningitis with radiological features of acute disseminated encephalomyelitis: a case report.
Optic neuritis in a psoriatic arthritis patient treated by infliximab.
[Magnetic reasonance spectroscopy-guided stereotactic biopsy for brain lesion].
Epidemiology in multiple sclerosis: a pilgrim's progress.
Myelination at a glance.
Riluzole.
Synthesis of fluorinated analogues of sphingosine-1-phosphate antagonists as potential radiotracers for molecular imaging using positron emission tomography.
Behavioral Neurology of Multiple Sclerosis and Autoimmune Encephalopathies.
Expanding the Clinical Indications for Alpha-1-Antitrypsin Therapy.
[Emerging therapies for multiple sclerosis.]

Pages